Comparison of Dose Distribution with Graphical Optimization and Inverse Planning Techniques in Cervical Cancer Brachytherapy
DOI:
10.29303/jppipa.v12i2.12900Published:
2026-02-28Downloads
Abstract
Cervical cancer is the leading cause of death among women in Indonesia, with 36,964 new cases reported in 2022. Brachytherapy is a key component in treating advanced-stage cervical cancer, where dose optimization is critical to maximize the target dose (HRCTV) and minimize exposure to organs at risk. Graphical Optimization (GrO) and Inverse Planning (IP) techniques are commonly used, but comparative studies using Co-60 sources remain limited. Previous studies have largely used Ir‑192, so this study explores the comparison of GrO versus IP using Co‑60, which has not been widely studied in Indonesia. Co‑60 was chosen because it provides a dose distribution comparable to Ir‑192, has a longer half‑life reducing the frequency of source replacements and maintenance costs and has been reported to shorten patient treatment time by approximately 10%. This study compared the dose distribution of both techniques in 30 brachytherapy patients treated with a Co-60 source at Prof. Dr. I.G.N.G. Ngoerah Hospital. Data were analyzed using the Sagiplan 2.2.1 Treatment Planning System (TPS) following the TG-43 protocol. Evaluations included D90 HRCTV, COIN, DHI, bladder D2cc, and rectum D2cc based on ICRU Report 89 recommendations. MANOVA results (SPSS 29.0; significance < 0.05) showed that GrO’s D90 HRCTV (7.239 Gy ± 0.134 Gy) was significantly higher (sig = 0.006) than IP (7.155 Gy ± 0.093 Gy). GrO’s DHI (0.352 ± 0.043) was also superior (sig = 0.030), while COIN, bladder D2cc, and rectum D2cc showed no significant differences. Overall dose distribution for GrO differed significantly from IP (p = 0.011), though all parameters met ICRU standards. Conclusion: GrO excels in target coverage and homogeneity, while IP is equivalent in OAR protection. Both techniques are dosimetrically feasible, but GrO is more adaptive for complex anatomies despite requiring longer planning time.
Keywords:
Brachytherapy Cervical cancer Dose distribution Graphical optimization (GrO) Inverse planning (IP)References
Abdel, M. W., Gondhowiardjo, S. S., Arthur, ;, Rosa, A., Lievens, Y., Noura El-Haj, ;, Jose, ;, Rubio, A. P., Gregorius, ;, Prajogi, B., Helgadottir, H., Zubizarreta, ; Eduardo, Meghzifene, A., Ashraf, V., Hahn, S., Williams, T., & Gospodarowicz, M. (2021). Global Radiotherapy: Current Status and Future Directions-White Paper. In JCO Global Oncol (Vol. 7). https://ascopubs.org/go/authors/open-access
Aldelaijan, S. I., Papaconstadopoulos, P., Schneider, J., Bekerat, H., Seuntjens, J., Buzurovic, I., & Devic, S. (2018). Decomposition of Source Dwell Positions and Dwell Times: A Novel Method for Accurate Source Tracking and Quality Assurance in HDR Brachytherapy Based on Film Dosimetry. Brachytherapy, 17(4), S128–S129. https://doi.org/10.1016/j.brachy.2018.04.239
Baltas, D., Kolotas, C., Geramani, K., Mould, R. F., Ioannidis, G., Kekchidi, M., & Zamboglou, N. (1998). A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 40(2), 515–524. https://doi.org/10.1016/S0360-3016(97)00732-3
Bentzen, S. M., Boone, J. M., Brandan, M. E., Burns, D. T., Dawson, P., Fantuzzi, E., Gregoire, V., Howell, R. W., Mackie, T. R., Paretzke, S. H. G., Tatsuzaki, H., Allisy, A., Bartlett, D. T., & Seltzer, S. M. (2016). Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. Journal of the ICRU, 13(1–2). http://jicru.oxfordjournals.org/
Beyzadeoglu, M., Ozyigit, G., & Ebruli, C. (2010). Basic Radiation Oncology. In Basic Radiation Oncology. Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-11666-7
Dewi, S. M., Bennett, L. R., & Barrett, A. (2024). Exploring Indonesian Primary Schoolgirls’ Experiences of School-based HPV Vaccination, Knowledge of HPV Risks and Prevention, and Preferences for Cervical Cancer Education. Asian Pacific Journal of Cancer Prevention, 25(4), 1285–1292. https://doi.org/10.31557/APJCP.2024.25.4.1285
Doudoo, C. O., Gyekye, P. K., Emi-Reynolds, G., Adu, S., Kpeglo, D. O., Nii Adu Tagoe, S., & Agyiri, K. (2023). Dose and secondary cancer-risk estimation of patients undergoing high dose rate intracavitary gynaecological brachytherapy. Journal of Medical Imaging and Radiation Sciences, 54(2), 335–342. https://doi.org/10.1016/j.jmir.2023.03.031
Fotina, I., Zourari, K., Lahanas, V., Pantelis, E., & Papagiannis, P. (2018). A comparative assessment of inhomogeneity and finite patient dimension effects in 60Co and 192Ir high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy, 10(1), 73–84. https://doi.org/10.5114/jcb.2018.74327
Gül, O. V., Başaran, H., Duzova, M., & İnan, G. (2024). Dosimetric Comparison of Inverse Planning Simulated Annealing and Manual Optimization for Intracavitary Cervix Brachytherapy. Genel Tıp Dergisi, 34(1), 109–113. https://doi.org/10.54005/geneltip.1375470
Gul, O. V., Inan, G., & Basaran, H. (2021). Impact of different treatment plans on EQD2 for intracavitary brachytherapy of cervical cancer. Journal of the Egyptian National Cancer Institute, 33(1). https://doi.org/10.1186/s43046-021-00084-2
ICRU. (2013). ICRU Report 89, Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. In Journal of the ICRU (Vol. 13, Numbers 1–2). SAGE Publications. https://doi.org/10.1093/jicru/ndw028
Jayakody, M., Jeyasugiththan, J., Rajasooriyar, C., & Chougule, A. (2022). Dosimetry procedure to verify dose in High Dose Rate (HDR) brachytherapy treatment of cancer patients: A systematic review. In Physica Medica (Vol. 96, pp. 70–80). Associazione Italiana di Fisica Medica. https://doi.org/10.1016/j.ejmp.2022.02.022
Johansen, J. G., Kertzscher, G., Jørgensen, E. B., Rylander, S., Bentzen, L., Hokland, S. B., Søndergaard, C. S., With, A. K. M., Buus, S., & Tanderup, K. (2019). Dwell time verification in brachytherapy based on time resolved in vivo dosimetry. Physica Medica: European Journal of Medical Physics, 60, 156–161. https://doi.org/10.1016/j.ejmp.2019.03.031
Krishna, A., Lobo, J. L., MS, P., Makkapati, B. S., MS, A., Srinivas, C., Banerjee, S., Sunny, J., Simon, P., & Lobo, D. (2025). Evaluation and clinical relevance of plan quality indices in intracavitary brachytherapy for cervical cancer. F1000Research, 14, 882. https://doi.org/10.12688/f1000research.166604.1
Mosleh-Shirazi, M. A., Shahcheraghi-Motlagh, E., Gholami, M. H., Shakibafard, A., Karbasi, S., & Fardid, R. (2019). Influence of dwell time homogeneity error weight parameter on treatment plan quality in inverse optimized high-dose-rate cervix brachytherapy using SagiPlan. Journal of Contemporary Brachytherapy, 11(3), 256–266. https://doi.org/10.5114/jcb.2019.85903
Palled, S. R., Radhakrishna, N. K., Manikantan, S., Khanum, H., Venugopal, B. K., & Vishwanath, L. (2020). Dosimetric comparison of manual forward planning with uniform dwell times versus volume-based inverse planning in interstitial brachytherapy of cervical malignancies. Reports of Practical Oncology and Radiotherapy, 25(6), 851–855. https://doi.org/10.1016/j.rpor.2020.08.005
Pathak, P., Thomas, J. J., Baghwala, A., Li, C., Teh, B. S., Butler, E. B., & Farach, A. M. (2024). Personalized Brachytherapy: Applications and Future Directions. In Cancers (Vol. 16, Number 19). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cancers16193424
Petric, P., Dimopoulos, J., Kirisits, C., Berger, D., Hudej, R., & Pötter, R. (2008). Inter- and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiotherapy and Oncology, 89(2), 164–171. https://doi.org/10.1016/j.radonc.2008.07.030
Petrič, P., Pötter, R., Van Limbergen, E., & Haie-Meder, C. (2011). Adaptive contouring of the target volume and organs at risk. In Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management (pp. 99–118). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-68958-4_9
Puteri, A. P. (2020). Karsinoma Serviks: Gambaran Radiologi dan Terapi Radiasi. Cermin Dunia Kedokteran, 47(4), 277–286. https://doi.org/10.55175/cdk.v47i4.368
Roy, S., Subramani, V., Singh, K., & Rathi, A. (2021). Dosimetric impact of dwell time deviation constraint on inverse brachytherapy treatment planning and comparison with conventional optimization method for interstitial brachytherapy implants. Journal of Cancer Research and Therapeutics, 17(2), 463–470. https://doi.org/10.4103/jcrt.JCRT_749_19
Sadeghi, M. H., Sina, S., & Meigooni, A. S. (2021). A comparison of treatment duration for Cobalt-60 and Iridium-192 sources with different activities in HDR brachytherapy using tandem-ovoid applicator. Iranian Journal of Medical Physics, 18(5), 346–351. https://doi.org/10.22038/IJMP.2020.45759.1717
Sharma, A., Gasmi, M., Amresh, K., & Diksha, M. (2023). Enhancing Cervical Cancer Survival through Innovative Radiotherapy Interventions: A Narrative Review. Oncology and Radiotherapy, 10(17), 744–750. https://www.researchgate.net/publication/376581506_Enhancing_cervical_cancer_survival_through_innovative_radiotherapy_interventions_a_narrative_review
Shukla, A., Jangid, P., Rajpurohit, V., Verma, A., Dangayach, S., Gagrani, V., & Rathore, N. K. (2019). Dosimetric comparison of 60Co and 192Ir high dose rate source used in brachytherapy treatment of cervical cancer. Journal of Cancer Research and Therapeutics, 15(6), 1212–1215. https://doi.org/10.4103/jcrt.JCRT_372_19
Srivastava, S., Singh, N., & Varghese, M. (2022). Determination of variation in dosimetric parameters of treatment planning with Co-60 and Ir-192 sources in high dose rate brachytherapy of cervical carcinoma. Radiation Physics and Chemistry, 196. https://doi.org/10.1016/j.radphyschem.2022.110148
Suharmono, B. H., Emhayana, T., Fariha Dinata, B., & Dyah Astuti, S. (2021). Penatalaksanaan QA dan QC Untuk Efektivitas dan Keamanan Brakhiterapi Intrakaviter. Jurnal Biosains Pascasarjana, 23(02). https://doi.org/10.20473/jbp.v5i2.2021.87-98
Tamihardja, J., Weick, S., Lutyj, P., Zimmermann, M., Bratengeier, K., Flentje, M., & Polat, B. (2022). Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer. Acta Oncologica, 61(6), 714–719. https://doi.org/10.1080/0284186X.2022.2068968
Tang, B., Liu, X., Wang, X., Kang, S., Wang, P., Li, J., & Orlandini, L. C. (2019). Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer. Journal of Contemporary Brachytherapy, 11(4), 379–383. https://doi.org/10.5114/jcb.2019.87145
Utami, T. W., Nuranna, L., Rahman, S. A., Irzami, R., Utama, A., Purwoto, G., & Suarthana, E. (2025). A decade data of HPV genotypes in metropolitan regions of Indonesia: paving the way for a national cervical cancer elimination strategy. Journal of Gynecologic Oncology, 36(6). https://doi.org/10.3802/jgo.2025.36.e85
Vijande, J., Carlsson Tedgren, Å., Ballester, F., Baltas, D., Papagiannis, P., Rivard, M. J., Siebert, F. A., De Werd, L., & Perez-Calatayud, J. (2021). Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates. Physics and Imaging in Radiation Oncology, 19, 108–111. https://doi.org/10.1016/j.phro.2021.07.007
Wen, A., Wang, X., Wang, B., Yan, C., Luo, J., Wang, P., & Li, J. (2022). Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer. Cancers, 14(19). https://doi.org/10.3390/cancers14194749
Winarno, Audia Nurmansya, V., & Miskiyah, Z. (2021). Radioterapi Kanker Cervix dengan Linear Accelerator (LINAC). Jurnal Biosains Pascasarjana, 23(02). https://doi.org/10.20473/jbp.v5i2.2021.24-35
Wu, H., He, Y., Chen, D., Liu, M., & Zhao, X. (2024). High-dose-rate brachytherapy in uterine cervix carcinoma: a comparison of dosimetry and clinical outcomes among three fractionation schedules. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1366323
License
Copyright (c) 2026 Ni Nyoman Ratini, I Putu Wesa Angga Jaya, Gusti Ngurah Sutapa, I Putu Tedy Indrayana, Ni Putu Yuni Nurmalasari, I Wayan Balik Sudarsana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
